Literature DB >> 35412064

[Results of vagus nerve stimulator implantation in children and adolescents with treatment-refractory epilepsy].

Kim Vanessa Steinke1,2, Hartmut Möbius3,4, Hans-Jürgen Christen5, Hans-Jürgen Welkoborsky3,4.   

Abstract

Vagus nerve stimulation (VNS) is a therapeutic procedure that can be applied in a palliative setting in patients with treatment-refractory epilepsy who are not suitable for epilepsy surgery. The mechanism of action of VNS is currently not completely understood but appears to depend on a modification of neurotransmitter metabolism. Data of 25 patients with treatment-refractory epilepsy who underwent implantation of a vagus nerve stimulator were retrospectively analyzed in a monocentric study. A reduction in epileptic seizure rate of 28% was observed 3 months after initial activation and of 32.9% after 6-12 months. The responder rate (reduction in seizure rate of more than 50% compared to before implantation) was 40% 6-12 months after initial activation. In one third of patients, a reduction in epileptic seizure rate of at least 75% occurred. Adverse effects of surgery or the stimulation were rare.
© 2022. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Entities:  

Keywords:  Antiepileptic drugs; Drug-resistant epilepsy; Electric stimulation; Implantable neurostimulators; Pediatrics

Mesh:

Year:  2022        PMID: 35412064     DOI: 10.1007/s00106-022-01164-y

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  35 in total

1.  Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin.

Authors:  L V Borovikova; S Ivanova; M Zhang; H Yang; G I Botchkina; L R Watkins; H Wang; N Abumrad; J W Eaton; K J Tracey
Journal:  Nature       Date:  2000-05-25       Impact factor: 49.962

2.  Vagal nerve stimulation modifies neuronal activity and the proteome of excitatory synapses of amygdala/piriform cortex.

Authors:  Georgia M Alexander; Yang Zhong Huang; Erik J Soderblom; Xiao-Ping He; M Arthur Moseley; James O McNamara
Journal:  J Neurochem       Date:  2017-02-03       Impact factor: 5.372

3.  Regulation of limbic motor seizures by GABA and glutamate transmission in nucleus tractus solitarius.

Authors:  B R Walker; A Easton; K Gale
Journal:  Epilepsia       Date:  1999-08       Impact factor: 5.864

4.  Increased hippocampal noradrenaline is a biomarker for efficacy of vagus nerve stimulation in a limbic seizure model.

Authors:  Robrecht Raedt; Ralph Clinckers; Lies Mollet; Kristl Vonck; Riëm El Tahry; Tine Wyckhuys; Veerle De Herdt; Evelien Carrette; Wytse Wadman; Yvette Michotte; Ilse Smolders; Paul Boon; Alfred Meurs
Journal:  J Neurochem       Date:  2011-03-21       Impact factor: 5.372

Review 5.  Intractable epilepsy: management and therapeutic alternatives.

Authors:  Stephan U Schuele; Hans O Lüders
Journal:  Lancet Neurol       Date:  2008-06       Impact factor: 44.182

Review 6.  ILAE official report: a practical clinical definition of epilepsy.

Authors:  Robert S Fisher; Carlos Acevedo; Alexis Arzimanoglou; Alicia Bogacz; J Helen Cross; Christian E Elger; Jerome Engel; Lars Forsgren; Jacqueline A French; Mike Glynn; Dale C Hesdorffer; B I Lee; Gary W Mathern; Solomon L Moshé; Emilio Perucca; Ingrid E Scheffer; Torbjörn Tomson; Masako Watanabe; Samuel Wiebe
Journal:  Epilepsia       Date:  2014-04-14       Impact factor: 5.864

7.  Incidence of epilepsy in childhood and adolescence: a population-based study in Nova Scotia from 1977 to 1985.

Authors:  C S Camfield; P R Camfield; K Gordon; E Wirrell; J M Dooley
Journal:  Epilepsia       Date:  1996-01       Impact factor: 5.864

8.  Effects of vagus nerve stimulation on amino acids and other metabolites in the CSF of patients with partial seizures.

Authors:  E Ben-Menachem; A Hamberger; T Hedner; E J Hammond; B M Uthman; J Slater; T Treig; H Stefan; R E Ramsay; J F Wernicke
Journal:  Epilepsy Res       Date:  1995-03       Impact factor: 3.045

Review 9.  Ictal tachycardia: the head-heart connection.

Authors:  Katherine S Eggleston; Bryan D Olin; Robert S Fisher
Journal:  Seizure       Date:  2014-03-06       Impact factor: 3.184

10.  Vagal nerve stimulator: Evolving trends.

Authors:  Sunny Ogbonnaya; Chandrasekaran Kaliaperumal
Journal:  J Nat Sci Biol Med       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.